Accelerate to discover
Related topics
Early immune response in mice immunized with inactivated vaccine against SARS-CoV-2
Nov 19, 2020
The development of a vaccine against COVID-19 is a hot topic for many research laboratories all over the world. Our aim...
Bruker announces software provider PMOD Technologies LLC
Nov 13, 2020
PMOD Technologies aims to equip researchers with best-in-class software tools for biomedical imaging research in humans...
Microvascular injury in mild traumatic brain injury accelerates alzheimer-like pathogenesis in mice
Nov 9, 2020
Traumatic brain injury (TBI) is considered as the most robust environmental risk factor for Alzheimer’s disease (AD)....
Live animal imaging - Humane animal research
Oct 26, 2020
Drawing on over 50 years of expertise in the life and animal sciences, Bruker designs preclinical imaging systems that...
Meet the Expert - Brent Barre interview
Oct 21, 2020
Learn what a researcher at the forefront of COVID-19 research has to say about his current research environment.
Automated fever & hypothermia detection
Oct 14, 2020
As one of the oldest clinical indicators of disease in mammals, temperature is a crucial parameter to monitor,...
Multi-modal molecular imaging driving pre-clinical research & pharmaceutical development
Oct 6, 2020
Multi-modal molecular imaging at Massachusetts General Hospital – driving pre-clinical research and patient pathways...
Imaging Performance of a multimodal module to enhance preclinical irradiator capabilities
Sep 15, 2020
Upgrading an existing irradiator with such a multi-modal imaging device is a reasonable investment in laboratories...
Oct 25, 2017
The purpose of this study was to investigate the cytotoxic effect of hyperthermia and cisplatin on OVCAR-3 cells in vitro. Imitating the typical clinical conditions of HIPEC, OVCAR-3 cells were exposed to hyperthermia and cisplatin for 1 h. MTT viability test, flow cytometric analysis, and real-time cell and isobologram analysis were performed. Hyperthermia up to 42˚C did not significantly increase the effect of cisplatin regarding the viability and apoptosis of OVCAR-3 cells. Moreover, an antagonistic effect of hyperthermia and cisplatin was revealed. Dr.Jasukaitiene investigation of OVCAR-3 cells, critically disputes the benefit of hyperthermia in ovarian cancer treatment. Further in vitro and in vivo research is essential for better understanding of the mechanisms of action of hyperthermia and its role in the treatment of epithelial ovarian cancer.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
